DLHCX
Price
$20.90
Change
-$0.03 (-0.14%)
Updated
Jul 25 closing price
Net Assets
647.12M
FBTAX
Price
$28.16
Change
+$0.01 (+0.04%)
Updated
Jul 25 closing price
Net Assets
1.3B
Interact to see
Advertisement

DLHCX vs FBTAX

Header iconDLHCX vs FBTAX Comparison
Open Charts DLHCX vs FBTAXBanner chart's image
Macquarie Healthcare C
Price$20.90
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets647.12M
Fidelity Advisor Biotechnology A
Price$28.16
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets1.3B
DLHCX vs FBTAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLHCX vs. FBTAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and FBTAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.3B vs. DLHCX (647M). FBTAX pays higher dividends than DLHCX: FBTAX (2.95) vs DLHCX (0.00). DLHCX was incepted earlier than FBTAX: DLHCX (16 years) vs FBTAX (25 years). DLHCX (2.00) is less costly to investors than FBTAX (0.96). FBTAX is a more actively managed with annual turnover of: 73.00 vs. DLHCX (5.00). FBTAX has a lower initial minimum investment than DLHCX: FBTAX (0) vs DLHCX (1000). FBTAX annual gain was more profitable for investors over the last year : -10.87 vs. DLHCX (-19.49). FBTAX return over 5 years is better than : -6.61 vs. DLHCX (-19.12).
DLHCXFBTAXDLHCX / FBTAX
Total Expense Ratio1.960.96204%
Annual Report Gross Expense Ratio2.000.96208%
Fund Existence16 years25 years-
Gain YTD-0.3813.491-11%
Front LoadN/A6%-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets647M1.3B50%
Annual Yield % from dividends0.002.95-
Returns for 1 year-19.49-10.87179%
Returns for 3 years-12.9531.49-41%
Returns for 5 years-19.12-6.61289%
Returns for 10 years1.65-6.23-27%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLPG32.651.80
+5.83%
Galapagos NV
ALV117.351.50
+1.29%
Autoliv
CMPX3.180.02
+0.63%
Compass Therapeutics
SLRX0.75N/A
-0.17%
Salarius Pharmaceuticals Inc.
PYXS1.25-0.09
-6.72%
Pyxis Oncology